Literature DB >> 19478516

Genetics in clinical trials.

James F Meschia, Katrina Gwinn.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19478516      PMCID： PMC2789592          DOI： 10.1159/000209494

Source DB:  PubMed          Journal:  Front Neurol Neurosci        ISSN： 0300-5186


× No keyword cloud information.
  30 in total

1.  Differential qualitative responses to rivastigmine in APOE epsilon 4 carriers and noncarriers.

Authors:  M Farlow; R Lane; S Kudaravalli; Y He
Journal:  Pharmacogenomics J       Date:  2004       Impact factor: 3.550

2.  Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.

Authors: 
Journal:  JAMA       Date:  1998 Apr 22-29       Impact factor: 56.272

3.  Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1.

Authors:  Asra Siddiqui; Reinhold Kerb; Michael E Weale; Ulrich Brinkmann; Alice Smith; David B Goldstein; Nicholas W Wood; Sanjay M Sisodiya
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

Review 4.  The long QT syndrome: ion channel diseases of the heart.

Authors:  M J Ackerman
Journal:  Mayo Clin Proc       Date:  1998-03       Impact factor: 7.616

5.  Apolipoprotein E genotype and gender influence response to tacrine therapy.

Authors:  M R Farlow; D K Lahiri; J Poirier; J Davignon; S Hui
Journal:  Ann N Y Acad Sci       Date:  1996-12-16       Impact factor: 5.691

6.  Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease.

Authors:  M R Farlow; D K Lahiri; J Poirier; J Davignon; L Schneider; S L Hui
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

7.  Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia.

Authors:  T Kapitany; K Meszaros; E Lenzinger; S D Schindler; C Barnas; K Fuchs; W Sieghart; H N Aschauer; S Kasper
Journal:  Schizophr Res       Date:  1998-07-27       Impact factor: 4.939

8.  Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.

Authors:  J P Vandenbroucke; T Koster; E Briët; P H Reitsma; R M Bertina; F R Rosendaal
Journal:  Lancet       Date:  1994-11-26       Impact factor: 79.321

Review 9.  Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force.

Authors: 
Journal:  Arch Neurol       Date:  1989-07

10.  Presence or absence of at least one epsilon 4 allele and gender are not predictive for the response to donepezil treatment in Alzheimer's disease.

Authors:  Anne-Sophie Rigaud; Latchezar Traykov; Florence Latour; Rémy Couderc; Florence Moulin; Françoise Forette
Journal:  Pharmacogenetics       Date:  2002-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.